Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children.
BACKGROUND
Diseases associated with Epstein-Barr virus (EBV) infections, such as infectious mononucleosis (IM), EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) and chronic active EBV infection (CAEBV) are not rare in Chinese children. The association of type 1 or type 2 EBV and variants of the EBV BZLF1 promoter zone (Zp) with these diseases is unclear.


RESULTS
The objective of this study was to investigate the relationship between EBV genotypes (Zp variants and EBV type 1 and 2) and the clinical phenotypes of EBV-associated diseases in Chinese children. The Zp region was directly sequenced in 206 EBV-positive DNA samples from the blood of patients with IM, EBV-HLH, CAEBV, and healthy controls. Type 1 or type 2 EBV was examined by PCR for EBNA2 and EBNA3C subtypes. Four polymorphic Zp variants were identified: Zp-P, Zp-V3, Zp-P4 and Zp-V1, a new variant. The Zp-V3 variant was significantly associated with CAEBV (P <or= 0.01). The frequency of co-infection with Zp variants was higher in patients with CAEBV and EBV-HLH, compared with IM and healthy controls, mostly as Zp-P+V3 co-infection. Type 1 EBV was predominant in all categories (81.3-95%) and there was no significant difference in the frequency of the EBV types 1 and 2 in different categories (P > 0.05).


CONCLUSIONS
Type 1 EBV and BZLF1 Zp-P of EBV were the predominant genotypes in nonmalignant EBV associated diseases in Chinese children and Zp-V3 variant may correlates with the developing of severe EBV infection diseases, such as CAEBV and EBV-HLH.
Jin
Yingkang
Y
Department of Infection, Beijing Children's Hospital, The Capital Medical University, Beijing, China.
Xie
Zhengde
Z
Lu
Gen
G
Yang
Shuang
S
Shen
Kunling
K
D001483:Base Sequence; D002648:Child; D002675:Child, Preschool; D002681:China; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D020031:Epstein-Barr Virus Infections / Q000473:pathology* / Q000821:virology*; D004854:Herpesvirus 4, Human / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D017422:Sequence Analysis, DNA; D015534:Trans-Activators / Q000235:genetics*
C063676:BZLF1 protein, Herpesvirus 4, Human; D004279:DNA, Viral; D015534:Trans-Activators
Blood. 1996 Nov 1;88(9):3491-501
8896415
Scand J Infect Dis. 1987;19(3):373-9
3039653
Arch Pathol Lab Med. 1991 May;115(5):470-4
1850588
J Virol. 1990 Sep;64(9):4084-92
2166806
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
16937360
J Virol. 2000 Feb;74(4):1801-9
10644353
J Gen Virol. 1991 Oct;72 ( Pt 10):2399-409
1681026
J Natl Cancer Inst. 2002 Dec 4;94(23):1757-63
12464647
Blood. 2001 Jul 15;98(2):280-6
11435294
J Virol. 1996 Oct;70(10):7301-5
8794387
J Gen Virol. 1999 Feb;80 ( Pt 2):441-445
10073706
Blood. 1996 Jul 1;88(1):242-51
8704180
Oncogene. 1992 Nov;7(11):2131-40
1331932
J Infect. 2007 Mar;54(3):298-306
16784778
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632-6
6209719
Am J Hematol. 2005 Sep;80(1):64-9
16138335
J Natl Cancer Inst. 2003 Jul 2;95(13):1008-9; author reply 1009
12837838
Int J Hematol. 1997 Aug;66(2):135-51
9277044
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):85-8
6222781